华峰化学：10月23日召开董事会会议

Group 1 - The core point of the article is that Huafeng Chemical held its 14th meeting of the 9th Board of Directors on October 23, 2025, via telecommunication voting, discussing the establishment of the Audit Committee members and the convener [1] - For the first half of 2025, Huafeng Chemical's revenue composition was 99.44% from industrial operations and 0.56% from logistics services [1] - As of the report date, Huafeng Chemical's market capitalization was 43.5 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year, indicating a hot secondary market in biomedicine [1] - There is a contrast presented regarding the fundraising situation in the primary market, which is facing challenges [1]